Fig. 4

Adjusted association between fasting glucose and markers of glycaemia, (A) HbA1c, (B) glycated albumin, (C) fructosamine, dichotomized by CKD status, in those with confirmed type 2 diabetes. Data is presented as (1) linear predictive margins for those with CKD (dashed line) and those without CKD (solid line) with 95% CI and (2) the average marginal effect (dy/dx), 95% CI and p-value indicating association between FPG levels and markers of glycaemia, for those with and without CKD.